ES2157196T3 - Polipeptidos y adn codificador de los mismos, asociados con parasitos de la malaria humana. - Google Patents

Polipeptidos y adn codificador de los mismos, asociados con parasitos de la malaria humana.

Info

Publication number
ES2157196T3
ES2157196T3 ES91903249T ES91903249T ES2157196T3 ES 2157196 T3 ES2157196 T3 ES 2157196T3 ES 91903249 T ES91903249 T ES 91903249T ES 91903249 T ES91903249 T ES 91903249T ES 2157196 T3 ES2157196 T3 ES 2157196T3
Authority
ES
Spain
Prior art keywords
same
parasites
polypeptides
coding dna
human malaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91903249T
Other languages
English (en)
Inventor
Kathryn Jane Hallowes Robson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Application granted granted Critical
Publication of ES2157196T3 publication Critical patent/ES2157196T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION PROPORCIONA PROTEINAS DE LA FASE DEL MEROZOITO DEL PARASITO DE LA MALARIA QUE FORMAN UNA SECUENCIA CONSERVADA EN UNA SECUENCIA DE EXTENSION, FRAGMENTOS Y DERIVADOS DEL MISMO, CODIFICACION DEL ADN PARA LAS PROTEINAS Y PROCESOS PARA LA PREPARACION DE LAS PROTEINAS Y VECTORES PLASMIDOS Y VIRALES UTILES EN DICHOS PROCESOS. LA INVENCION TAMBIEN PROPORCIONA ANTICUERPOS PARA LAS PROTEINAS Y COMPOSICIONES INMUNOLOGICAS QUE LOS CONTIENEN.
ES91903249T 1990-02-05 1991-02-04 Polipeptidos y adn codificador de los mismos, asociados con parasitos de la malaria humana. Expired - Lifetime ES2157196T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909002512A GB9002512D0 (en) 1990-02-05 1990-02-05 Polypeptides and dna encoding same

Publications (1)

Publication Number Publication Date
ES2157196T3 true ES2157196T3 (es) 2001-08-16

Family

ID=10670433

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91903249T Expired - Lifetime ES2157196T3 (es) 1990-02-05 1991-02-04 Polipeptidos y adn codificador de los mismos, asociados con parasitos de la malaria humana.

Country Status (10)

Country Link
EP (1) EP0514411B1 (es)
JP (1) JP3067206B2 (es)
AT (1) ATE201046T1 (es)
AU (1) AU643506B2 (es)
DE (1) DE69132599T2 (es)
DK (1) DK0514411T3 (es)
ES (1) ES2157196T3 (es)
GB (1) GB9002512D0 (es)
GR (1) GR3036312T3 (es)
WO (1) WO1991011516A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0513421D0 (en) 2005-06-30 2005-08-03 Glaxosmithkline Biolog Sa Vaccines
AP2010005166A0 (en) 2007-08-13 2010-02-28 Glaxosmithkline Biolog Sa Vaccines
US9580482B2 (en) 2012-02-17 2017-02-28 Children's Medical Center Corporation Conformation-stabilized TRAP antigens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
GB8706599D0 (en) * 1987-03-19 1987-04-23 Hoffmann La Roche Plasmodium falciparum merozoite antigen peptides
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same

Also Published As

Publication number Publication date
DE69132599T2 (de) 2002-05-29
JPH05503937A (ja) 1993-06-24
WO1991011516A1 (en) 1991-08-08
GR3036312T3 (en) 2001-10-31
DE69132599D1 (de) 2001-06-13
ATE201046T1 (de) 2001-05-15
GB9002512D0 (en) 1990-04-04
EP0514411A1 (en) 1992-11-25
EP0514411B1 (en) 2001-05-09
AU643506B2 (en) 1993-11-18
JP3067206B2 (ja) 2000-07-17
AU7231591A (en) 1991-08-21
DK0514411T3 (da) 2001-05-28

Similar Documents

Publication Publication Date Title
DE69021002D1 (de) Schimärische Hepadnavirus-Kernantigenproteine.
FI104255B1 (fi) Menetelmä ihmisen seerumialbumiinin N-terminaalifragmentteja sisältävien fuusioproteiinien valmistamiseksi
DK94783A (da) Fremgangsmaade til fremstilling af kvaternaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl-norscopinethere og mellemprodukter herfor
ES2091861T3 (es) Proteinas antigenicas y vacunas que las contienen para la prevencion de la coccidiosis.
AT369346B (de) Glas, insbesondere in form von praezisionspressgegenstaenden
ATE109795T1 (de) Htlv-iii umhüllende peptiden.
DK0604418T3 (da) Isolerede viralproteincytokinantagonister
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
ES2157196T3 (es) Polipeptidos y adn codificador de los mismos, asociados con parasitos de la malaria humana.
DK85589A (da) Ekspression af hiv-bindende proteiner
FI896242A7 (fi) HIV-ENV-proteiineihin liittyviä synteettisiä peptidejä
DE3879968D1 (de) Malaria-impfstoff aus copolymerem protein.
PT625157E (pt) Epitopes p1a1 e p1a2 da gpiiia da plaqueta sua preparacao e utilizacao
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
ES2063754T3 (es) Un antigeno especifico del genero listeria identificado por anticuerpos monoclonales.
AR006150A1 (es) Proteina de via complementaria natural modificada capaz de formar una convertasa c3 resistente a la regulacion descendente, secuencias de adn quecodifican dicha proteina, usos de dicha proteina y composiciones que la contienen
DK36988D0 (da) Ekspression af p.falciparum-circumsporozoitprotein af gaer
EP0652769A1 (en) Vaccines against Metazoon parasites.
DK569886D0 (da) Fremstilling af human somatomedin c
FI915333A7 (fi) T-lymfotrooppisten retrovirusten monoklonaalisia vasta-aineita
ITRM910385A0 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni.
SE8803062D0 (sv) Sequential polypeptides endowed with immunological activity
DK169889A (da) Fremgangsmaade til fremstilling af proteiner, der n-terminalt begynder med prolin
DK460987D0 (da) Fremstilling af proteiner.
IT8820278A0 (it) Derivati del bisbenzotrifluoruro e metodo di preparazione degli stessi.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 514411

Country of ref document: ES